HRT Financial’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,200
Closed -$3.14M 3715
2025
Q4
$3.14M Buy
+22,200
New +$2.52M 0.01% 1018
2024
Q1
Sell
-7,700
Closed -$1.11M 2235
2023
Q4
$1.11M Buy
+7,700
New +$1.06M 0.01% 934
2023
Q3
Sell
-1,400
Closed -$312K 2340
2023
Q2
$312K Buy
+1,400
New +$286K ﹤0.01% 1604
2023
Q1
Sell
-1,000
Closed -$216K 2436
2022
Q4
$216K Buy
+1,000
New +$267K ﹤0.01% 1903

Other funds holding ALB

HRT Financial's ALB Position: Q1 2026 in Review

HRT Financial sold out of Albemarle (ALB) in Q1 2026, closing a stake of 87,513 shares — an estimated $14.9M sold.

HRT Financial first reported a position in ALB in Q4 2019 and held it in 13 quarters. The position peaked at $12.4M in Q4 2025. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • HRT Financial reported no remaining Albemarle position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 87,513 Albemarle shares in Q1 2026, an estimated $14.9M.
  • HRT Financial first reported a position in Albemarle in Q4 2019 and held it in 13 quarters.
  • HRT Financial's Albemarle position peaked at $12.4M in Q4 2025.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.